Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310781981> ?p ?o ?g. }
- W4310781981 endingPage "196" @default.
- W4310781981 startingPage "182" @default.
- W4310781981 abstract "An ultrasonic method (20 kHz) is introduced to activate pristine ibuprofen organic molecular crystals via complexation with silver in nitrogen-doped oxidized graphene nanoplatforms (∼50 nm). Ultrasonic complexation occurs in a single-step procedure through the binding of the carboxylic groups with Ag and H-bond formation, involving noncovalent πC=C → πC=C* transitions in the altered phenyl ring and πPY → πCO* in ibuprofen occurring between the phenyl ring and C–O bonds as a result of interaction with hydroxyl radicals. The ibuprofen–silver complex in ≪NrGO≫ exhibits a ∼42 times higher acceleration rate than free ibuprofen of the charge transfer between hexacyanoferrate and thiosulfate ions. The increased acceleration rate can be caused by electron injection/ejection at the interface of the ≪Ag-NrGO≫ nanoplatform and formation of intermediate species (Fe(CN)5(CNSO3)x− with x = 4 or 5 and AgHS2O3) at the excess of produced H+ ions. Important for microwave chemotherapy, ibuprofen–silver complexes in the ≪NrGO≫ nanoplatform can produce H+ ions at ∼12.5 times higher rate at the applied voltage range from 0.53 to 0.60 V. ≪Ibu-Ag-NrGO≫ NPs develop ∼105 order higher changes of the electric field strength intensity than free ibuprofen in the microwave absorption range of 100–1000 MHz as revealed from the theoretical modeling of a cervix tumor tissue." @default.
- W4310781981 created "2022-12-17" @default.
- W4310781981 creator A5004241837 @default.
- W4310781981 creator A5004920801 @default.
- W4310781981 creator A5010496583 @default.
- W4310781981 creator A5017716105 @default.
- W4310781981 creator A5065756143 @default.
- W4310781981 creator A5068805259 @default.
- W4310781981 date "2022-12-06" @default.
- W4310781981 modified "2023-10-17" @default.
- W4310781981 title "Activation of Ibuprofen via Ultrasonic Complexation with Silver in N-Doped Oxidized Graphene Nanoparticles for Microwave Chemotherapy of Cervix Tumor Tissues" @default.
- W4310781981 cites W1250630852 @default.
- W4310781981 cites W1912498426 @default.
- W4310781981 cites W1968203808 @default.
- W4310781981 cites W1974214446 @default.
- W4310781981 cites W1985040806 @default.
- W4310781981 cites W1988140746 @default.
- W4310781981 cites W1990528577 @default.
- W4310781981 cites W1997284006 @default.
- W4310781981 cites W1998607250 @default.
- W4310781981 cites W2000972943 @default.
- W4310781981 cites W2012709302 @default.
- W4310781981 cites W2018982704 @default.
- W4310781981 cites W2024376837 @default.
- W4310781981 cites W2031670446 @default.
- W4310781981 cites W2037734347 @default.
- W4310781981 cites W2040594622 @default.
- W4310781981 cites W2050511577 @default.
- W4310781981 cites W2054768809 @default.
- W4310781981 cites W2058272047 @default.
- W4310781981 cites W2063454088 @default.
- W4310781981 cites W2070174862 @default.
- W4310781981 cites W2077098077 @default.
- W4310781981 cites W2080667476 @default.
- W4310781981 cites W2083199294 @default.
- W4310781981 cites W2084981388 @default.
- W4310781981 cites W2091273808 @default.
- W4310781981 cites W2096853511 @default.
- W4310781981 cites W2125399149 @default.
- W4310781981 cites W2129136350 @default.
- W4310781981 cites W2131090849 @default.
- W4310781981 cites W2140746165 @default.
- W4310781981 cites W2157234518 @default.
- W4310781981 cites W2167035995 @default.
- W4310781981 cites W2168904174 @default.
- W4310781981 cites W2169997727 @default.
- W4310781981 cites W2171898868 @default.
- W4310781981 cites W2235679284 @default.
- W4310781981 cites W2312546240 @default.
- W4310781981 cites W2322631124 @default.
- W4310781981 cites W2341440492 @default.
- W4310781981 cites W2476770291 @default.
- W4310781981 cites W2518139912 @default.
- W4310781981 cites W2552944665 @default.
- W4310781981 cites W2554773181 @default.
- W4310781981 cites W2607498870 @default.
- W4310781981 cites W2608759624 @default.
- W4310781981 cites W2739962352 @default.
- W4310781981 cites W2754835802 @default.
- W4310781981 cites W2767392060 @default.
- W4310781981 cites W2773078544 @default.
- W4310781981 cites W2783587289 @default.
- W4310781981 cites W2785337126 @default.
- W4310781981 cites W2790154782 @default.
- W4310781981 cites W2810334192 @default.
- W4310781981 cites W2911851724 @default.
- W4310781981 cites W2914644541 @default.
- W4310781981 cites W2939826726 @default.
- W4310781981 cites W3004440766 @default.
- W4310781981 cites W3049458647 @default.
- W4310781981 cites W3096133570 @default.
- W4310781981 cites W3100128198 @default.
- W4310781981 cites W3116162180 @default.
- W4310781981 cites W3138156562 @default.
- W4310781981 cites W3193289099 @default.
- W4310781981 cites W3197289986 @default.
- W4310781981 cites W3205668695 @default.
- W4310781981 doi "https://doi.org/10.1021/acsbiomaterials.2c01045" @default.
- W4310781981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36472577" @default.
- W4310781981 hasPublicationYear "2022" @default.
- W4310781981 type Work @default.
- W4310781981 citedByCount "0" @default.
- W4310781981 crossrefType "journal-article" @default.
- W4310781981 hasAuthorship W4310781981A5004241837 @default.
- W4310781981 hasAuthorship W4310781981A5004920801 @default.
- W4310781981 hasAuthorship W4310781981A5010496583 @default.
- W4310781981 hasAuthorship W4310781981A5017716105 @default.
- W4310781981 hasAuthorship W4310781981A5065756143 @default.
- W4310781981 hasAuthorship W4310781981A5068805259 @default.
- W4310781981 hasConcept C121332964 @default.
- W4310781981 hasConcept C139066938 @default.
- W4310781981 hasConcept C13965031 @default.
- W4310781981 hasConcept C161790260 @default.
- W4310781981 hasConcept C171250308 @default.
- W4310781981 hasConcept C178790620 @default.
- W4310781981 hasConcept C185592680 @default.
- W4310781981 hasConcept C192562407 @default.
- W4310781981 hasConcept C2779944601 @default.